Brain Metastases

Most common brain tumor in adults - spread of cancer from elsewhere in the body to the brain

H01 Topic Guide

Neuro-Oncology: Brain Tumors

This hub page brings together 16 conditions under Neuro-Oncology: Brain Tumors. Use it to move from overview content to the relevant disease detail pages.

Open topic guide

1Overview

Quick and clear information for patients

What is this Condition?

Symptoms

Headache - persistent, progressively worsening, may be worse in the morning (most common symptom)
Weakness in a body area, speech disturbance, or visual field loss (varies depending on lesion location)
Memory loss, difficulty concentrating, mental confusion, or personality changes
Seizures (convulsions similar to epilepsy) - can sometimes be the first symptom
Nausea and vomiting - especially in the morning
Balance disturbance and staggering gait (in focal lesions of the cerebellar region)
Vision problems - blurred vision, double vision, visual field loss
Speech difficulty - difficulty finding words or understanding speech, slurred speech
Excessive drowsiness, difficulty waking, confusion of consciousness in advanced cases
Stroke-like sudden onset symptoms - in some metastasis types prone to hemorrhage

Diagnosis Methods

Treatment Methods

Targeted radiation therapy (stereotactic radiosurgery - Gamma Knife / CyberKnife) - prominent in limited number of lesions
Surgical resection followed by cavity radiation therapy - for large, symptomatic lesions
Whole brain radiation therapy (with memory-sparing modern techniques) - for multiple lesions
Targeted drug therapies - drugs selected based on cancer's genetic characteristics and that reach the brain well
Immunotherapy-based treatments - especially effective in melanoma and lung cancer
Supportive therapy - corticosteroids to reduce edema and seizure-preventive medications

Frequently Asked Questions About Brain Metastases

Q1.What is brain metastasis? Which cancers most frequently spread to the brain?
Brain metastasis occurs when cancer cells from another part of the body reach the brain through the bloodstream and create new focal lesions. The tumor does not originate from the brain but from cancer in another organ. It is the most common tumor seen in the brain of adults. The cancers that most frequently spread to the brain are lung, breast, and skin (melanoma) cancers; these are followed by kidney and colorectal cancers. Most patients have multiple lesions.
Q2.What is the course of disease in patients with brain metastasis?
Prognosis varies greatly from patient to patient and depends on many factors: patient's age and general condition, type of primary cancer, presence of dissemination elsewhere in the body, and number of brain lesions. With today's targeted drugs and immunotherapy-based treatments, life expectancy has significantly extended in some patients. Especially in patients with limited lesions whose primary cancer is controlled, long-term results can be achieved with effective treatment. Therefore, a treatment plan is established individually for each patient.
Q3.Is surgery or radiation therapy better for brain metastasis?
Both have their place; selection is made based on the patient. Targeted radiation therapy (Gamma Knife / CyberKnife) is prominent in limited number, small to medium-sized, or deeply located lesions; does not require surgery, largely preserves cognitive function, and often allows same-day discharge. Surgery is preferred for large lesion, significant compression and edema, need for rapid relief, or when tissue sample is needed for diagnosis. In some cases, the appropriate approach may be a combination of both: the lesion is surgically removed, followed by radiation to the cavity to reduce recurrence probability.
Q4.Is whole brain radiation therapy (WBRT) still used now? What are its side effects?
Although its use has declined, it may still be necessary in certain situations: multiple lesions, meningeal dissemination, or rapid appearance of new lesions after targeted radiation. Modern techniques protecting the memory region and supportive medications are used to reduce side effects today. Early side effects may include fatigue, headache, hair loss, tinnitus, and nausea. Later effects may include cognitive impacts such as memory and attention difficulties. For this reason, in limited number of lesions, targeted radiation is preferred over whole brain radiation.
Q5.Are targeted drug therapies effective in brain metastasis?
Yes; targeted drugs that reach the brain well can be quite effective in brain metastasis and have provided significant progress in this field. These drugs are selected based on specific genetic characteristics carried by the primary cancer; for example, there are appropriate targeted drugs for certain lung cancer types, some melanoma and breast cancer types. These drugs can cross the blood-brain barrier and are usually more effective when used together with targeted radiation or surgery. Which drug is appropriate is determined by genetic tests on samples from the cancer.
Q6.Is immunotherapy effective in brain metastasis?
Yes; treatments that enhance the immune system against cancer cells can be effective in brain metastasis. Significant benefits have been seen especially in melanoma and lung cancer; with some combinations in melanoma, long-term responses are possible. These treatments sometimes show stronger effects when used together with targeted radiation therapy. Immunotherapy treatments have their own specific side effects, so this process is closely monitored.
Q7.When should brain MRI be performed in patients with lung or breast cancer?
Routine screening is not recommended for everyone; however, brain MRI is necessary in certain situations. If there are neurological symptoms such as headache, seizure, weakness, or mental changes, it should definitely be performed. Additionally, screening MRI may be recommended even without symptoms in certain cancer types and stages with high probability of brain dissemination. This decision is made by the oncology team that knows the cancer type and stage. Early detection of dissemination can expand treatment options.
Q8.What is meningeal dissemination (carcinomatous meningitis)? How is it treated?
Leptomeningeal spread is the dissemination of cancer cells to the membranes surrounding the brain and spinal cord and to the cerebrospinal fluid. Symptoms may include headache, neck stiffness, nausea and vomiting, double vision, facial palsy, hearing loss, and altered consciousness. Diagnosis uses contrast-enhanced MRI and examination of cerebrospinal fluid obtained from lumbar puncture; sometimes the procedure may need to be repeated several times. Treatment may include chemotherapy administered directly into the cerebrospinal fluid or intravenously, targeted drugs in appropriate patients, and radiation therapy to symptomatic sites. This is a serious condition requiring close follow-up.
Q9.Brain metastasis was detected without knowing the primary cancer source. What should be done?
In some patients, when brain metastasis is found, the location of the primary cancer is initially unknown. In this situation, a stepwise investigation is conducted to find the source: whole-body PET-CT and detailed tomography scans, tissue biopsy from the brain lesion if necessary, and advanced examination of the specimen (tests determining cell type and genetic characteristics), as well as directed evaluations such as skin examination, mammography, and colonoscopy. At the end of these investigations, the primary cancer is found in most patients. Until the source is identified, treatment directed at the lesion (radiation or surgery) and appropriate systemic therapies can be planned.
Q10.How is quality of life preserved in patients with brain metastasis?
Preserving quality of life is one of the most important goals of treatment. This requires treatment choices that preserve cognitive function (preferring targeted radiation when possible), symptom control (corticosteroids for edema, anticonvulsants for seizures, appropriate medications for pain and nausea), physical therapy and occupational therapy to support mobility and activities of daily living, psychological support and support groups, and when appropriate, early initiation of palliative care. A multidisciplinary team approach involving neurosurgery, radiation oncology, medical oncology, neurology, and rehabilitation is important. Support for family members and caregivers is an integral part of this process.

References

  1. Greenberg MS. Handbook of Neurosurgery. 10th ed. Thieme; 2023:910-920.
  2. Winn HR, ed. Metastatic Brain Tumors. In: Winn HR, ed. Youmans and Winn Neurological Surgery. 6th ed. Elsevier; 2011:1410-1422.
  3. Osborn AG, Hedlund GL, Salzman KL. Metastases and Paraneoplastic Syndromes. In: Osborn AG, Hedlund GL, Salzman KL. Osborn's Brain: Imaging, Pathology, and Anatomy. 2nd ed. Elsevier; 2018:842-846.
  4. Epidemiology of Brain Metastases. In: Brain Metastases: A Multidisciplinary Approach. Cham: Springer; 2018.
  5. Vogelbaum MA, Brown PD, Messersmith H, et al. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol. 2022:492-516.

This content is for informational purposes and based on academic sources; consult your physician for diagnosis and treatment.

Looking for Another Condition?

Search among 134 neurosurgical conditions

Popular searches:

Contact and Appointment

Assoc. Prof. Dr. Özgür AKŞAN

Browse Other Conditions

Popular searches:

Assoc. Prof. Dr. Özgür AKŞAN

Brain & Nerve Surgery

Book an appointment for detailed information and personalized treatment plan.

Book Appointment

Send Your MRI Images

Get a free preliminary evaluation via EmarYolla.com.

Send MRI

Our Services

Comprehensive Neurosurgery Services - A·B·C·H

What kind of help do you need?

Need help?

Book an appointment for expert evaluation.

Brain Metastases (ICD-10: C79.31) | Dr. Özgür AKŞAN